10 Best Scientific Instruments Stocks To Buy

Published on May 8, 2023 at 3:15 pm by Hamna Asim in Hedge Funds, News

In this article, we discuss 10 best scientific instruments stocks to buy. If you want to see more stocks in this selection, check out 5 Best Scientific Instruments Stocks To Buy.

Scientific instruments are tools used to measure, record, and indicate physical quantities, aiding in scientific research and new product development. These instruments are designed to accomplish theoretical research and can be used to measure, analyze, and verify the properties of materials and elements. Scientific instruments play a crucial role in developing new products and improving existing ones. As per Data Bridge Market Research, the scientific instruments market is predicted to increase from $41.13 billion in 2022 to $58.05 billion by 2030, experiencing a compound annual growth rate (CAGR) of 4.4% between 2023 and 2030.

According to the latest report by IMARC Group, the global market is being driven by the increasing emphasis on R&D in developing new products and the growing collaboration between governments and manufacturers to improve the effectiveness of scientific instruments. The growth of testing and research facilities in biotechnology and pharmaceuticals, along with heavy investments in the healthcare sector by many countries, is also contributing to market growth. Additionally, the rising demand for generics and biosimilars, and pharmaceutical companies’ focus on improving drug development processes and product quality, is driving the demand for high-quality scientific instruments. The market is further boosted by the growing need for better analysis equipment and the rapid advancements in neuroscience and applied microbiology.

Allied Market Research has categorized the global scientific instruments market into different segments. The firm stated that the clinical analyzers segment is expected to generate the highest revenue during the forecast period from 2021 to 2030, driven by the increasing adoption of point of care testing devices and laboratory automation, and the rise in chronic conditions that require clinical analyzers for diagnosis. Moreover, the research segment is expected to experience the fastest compound annual growth rate due to the rising demand for scientific instruments in the research of chronic conditions such as cardiovascular diseases, cancer, and neurological diseases, and the development of advanced instruments for research purposes. Lastly, the hospitals & diagnostic laboratories segment is the dominant end-user segment, driven by the escalating number of outpatients and inpatients in hospitals, and the adoption of newer methods and advanced instruments for research purposes in diagnostic laboratories.

To benefit from the growth opportunities in the scientific instruments market, investors can pick up stocks like Thermo Fisher Scientific Inc. (NYSE:TMO), Agilent Technologies, Inc. (NYSE:A), and Danaher Corporation (NYSE:DHR).

Our Methodology

We scanned Insider Monkey’s database of 943 hedge funds and picked the top 10 companies that operate in the scientific instruments sector with the highest number of hedge fund investors. These are the best scientific instruments stocks to buy according to hedge funds.

Vereshchagin Dmitry/Shutterstock.com

Best Scientific Instruments Stocks To Buy

10. Mirion Technologies, Inc. (NYSE:MIR)

Number of Hedge Fund Holders: 28

Mirion Technologies, Inc. (NYSE:MIR) offers a range of products and services related to the detection, measurement, analysis, and monitoring of radiation. The company is divided into two main segments – Medical and Industrial, each focusing on specific areas of expertise. Mirion Technologies, Inc. (NYSE:MIR) serves a wide range of customers including healthcare facilities, research laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and nuclear power plants. On May 3, the company reported a Q1 GAAP EPS of -$0.22 and a revenue of $182.1 million, up 11.6% year-over-year and beating estimates by $2.90 million.

On February 15, Citi analyst Andrew Kaplowitz raised the firm’s price target on Mirion Technologies, Inc. (NYSE:MIR) to $11 from $10 and maintained a Buy rating on the shares following the “solid” Q4 results. Kaplowitz considers Mirion’s initial 2023 guidance to be both cautious and promising, suggesting a continued growth trajectory for the company.

According to Insider Monkey’s fourth quarter database, 28 hedge funds were long Mirion Technologies, Inc. (NYSE:MIR), compared to 26 funds in the prior quarter. Anand Parekh’s Alyeska Investment Group is the largest stakeholder of the company, with 7.7 million shares worth $51.2 million.

Like Thermo Fisher Scientific Inc. (NYSE:TMO), Agilent Technologies, Inc. (NYSE:A), and Danaher Corporation (NYSE:DHR), Mirion Technologies, Inc. (NYSE:MIR) is one of the best scientific instruments stocks to invest in.

Here is what Baron Growth Fund has to say about Mirion Technologies, Inc. (NYSE:MIR) in its Q4 2021 investor letter:

“This quarter, the Fund initiated a position in Mirion Technologies, Inc., a leader in ionizing radiation detection and measurement technologies to the medical, laboratory, and nuclear power industries. The business consists of a portfolio of niche, mission-critical products that represent a small portion of a project’s costs but can cause extensive collateral damage if they fail. Products include dosimeters that monitor radiation levels of medical professionals, quality assurance equipment and software for nuclear medicine treatments, and instrumentation and equipment that is core to the construction, operation, and decommissioning of nuclear power plants.

We think that Mirion has the potential to be a compelling industrial compounder. The company is already the largest player in over 80% of its end markets, and in aggregate is approximately 3.5 times larger than its nearest competitor. We estimate that Mirion’s end markets should grow at 5% to 6% annually, driven by favorable secular trends and a consistent replacement cycle. We expect Mirion to grow in line with or ahead of its end markets on an organic basis, as it leverages its scale advantage to take modest market share. Organic growth should be complemented by Mirion’s successful acquisition strategy, driving aggregate growth into the double digit range. In addition, we believe the company has an opportunity to expand markets by 500 bps-plus of margin over time through a favorable mix shift, higher utilization rates, and ongoing M&A synergy realization.

We believe that Mirion boasts a capable and accomplished senior management team. CEO Tom Logan has been with the company since 2005 and has led the strategy that has grown Mirion’s revenues from $123 million at inception to approximately $700 million currently. The new chairman of Mirion, Larry Kingsley, has a strong history of shareholder value creation as the former CEO of industrial technology leaders Pall Corporation and IDEX Corporation. We think his expertise will be well utilized as Mirion embarks on its next stage of growth.”

9. Fortive Corporation (NYSE:FTV)

Number of Hedge Fund Holders: 33

Fortive Corporation (NYSE:FTV) specializes in the design, development, manufacturing, marketing, and servicing of professional and engineered products, software, and services. Fortive Corporation (NYSE:FTV)’s Intelligent Operating Solutions segment focuses on providing advanced instrumentation such as electrical test and measurement tools. These offerings cater to a wide range of industries such as manufacturing, process industries, healthcare, utilities and power, communications, electronics, and others. It is one of the best scientific instruments stocks to invest in.

On April 26, Fortive Corporation (NYSE:FTV) reported a Q1 non-GAAP EPS of $0.75 and a revenue of $1.46 billion, outperforming Wall Street estimates by $0.02 and $40 million, respectively.

JPMorgan analyst Stephen Tusa raised the firm’s price target on Fortive Corporation (NYSE:FTV) on April 27 to $78 from $77 and maintained an Overweight rating on the shares. The analyst informed investors that Fortive reported better-than-expected results for Q1, surpassing expectations in terms of organic growth and margins. As a result, the analyst has raised estimates to reflect the company’s strong performance at the beginning of the year.

According to Insider Monkey’s fourth quarter database, 33 hedge funds were bullish on Fortive Corporation (NYSE:FTV), compared to 29 funds in the prior quarter. Phill Gross and Robert Atchinson’s Adage Capital Management is the largest stakeholder of the company, with 4.48 million shares worth $288.3 million.

Cooper Investors made the following comment about Fortive Corporation (NYSE:FTV) in its Q4 2022 investor letter:

“Fortive Corporation (NYSE:FTV) completed several acquisitions and had probably its best year operationally since the 2016 spin-off from Danaher, reporting several quarters in a row of double-digit organic growth and margin expansion that beat market estimates. The business has now unlocked the potential we always saw in it, with software accounting for almost a quarter of revenues today, providing a nice element of recurring cash flow to support the more cyclical industrial parts of the group.”

8. Teledyne Technologies Incorporated (NYSE:TDY)

Number of Hedge Fund Holders: 34

Teledyne Technologies Incorporated (NYSE:TDY) delivers technological solutions that drive growth in industrial markets worldwide. The company’s Instrumentation segment specializes in providing monitoring and control instruments used in marine, environmental, industrial, and other applications. Additionally, Teledyne Technologies Incorporated (NYSE:TDY) offers electronic test and measurement equipment, as well as power and communications connectivity devices for distributed instrumentation systems and sensor networks. It is one of the best scientific instruments stocks to watch.

On April 26, Teledyne Technologies Incorporated (NYSE:TDY) reported a Q1 non-GAAP EPS of $4.53 and a revenue of $1.38 billion, topping Wall Street estimates by $0.10 and $10 million, respectively.

Needham analyst James Ricchiuti maintained a Buy rating on Teledyne Technologies Incorporated (NYSE:TDY) but lowered the firm’s price target on the shares to $470 on April 28. The analyst informed investors that Teledyne Technologies Incorporated (NYSE:TDY)’s Q1 results were considered solid, with consistent demand and margins. However, the company’s earnings guidance fell short of consensus expectations. Nevertheless, Needham highlights Teledyne Technologies Incorporated (NYSE:TDY)’s diverse portfolio of businesses, its demonstrated track record of success even in uncertain economic times, and its strong financial position, all of which should provide support to the stock at its current levels.

According to Insider Monkey’s fourth quarter database, 34 hedge funds were long Teledyne Technologies Incorporated (NYSE:TDY), compared to 38 funds in the prior quarter. Select Equity Group is the biggest stakeholder of the company, with 2.26 million shares worth $906 million.

Here is what Artisan Partners specifically said about Teledyne Technologies Incorporated (NYSE:TDY) in its Q2 2022 investor letter:

“We trimmed our position in Teledyne Technologies Incorporated (NYSE:TDY) during Q2 as shares approached our PMV estimate. Teledyne is a supplier of enabling technologies to sense, transmit and analyze information for a diverse group of end markets, including aerospace & defense, factory automation, medical imaging, oil & gas, pharmaceutical research and environmental monitoring. The company is delivering healthy organic growth despite headwinds from semiconductor shortages, led by particular strength in its dental and industrial imaging. Margins and cash flows have accelerated as management has successfully integrated its 2021 acquisition of FLIR Systems, a leader in thermal imaging systems. Meanwhile, Teledyne’s shares have recently benefited from an anticipated increase in demand from Western governments seeking to supply Ukraine with military equipment. The company’s aerospace and defense segment is not core to our thesis—Teledyne’s margins and top-line growth have benefited for over a decade from reducing exposure to this area and placing more emphasis on asset-light businesses—though in the current environment it will likely experience a period of elevated demand.”

7. PerkinElmer, Inc. (NYSE:PKI)

Number of Hedge Fund Holders: 34

PerkinElmer, Inc. (NYSE:PKI) offers a wide range of products, services, and solutions to various markets including diagnostics, life sciences, and applied services. The company operates through two main segments – Discovery & Analytical Solutions and Diagnostics. Via the Discovery & Analytical Solutions segment, PerkinElmer, Inc. (NYSE:PKI) provides scientists with instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies. These offerings aim to facilitate research breakthroughs in the life sciences research market, as well as provide contract research and laboratory services. It is one of the premier scientific instruments stocks to invest in.

On March 9, Citi analyst Patrick Donnelly put “positive catalyst watches” on shares of PerkinElmer, Inc. (NYSE:PKI) following the Q4 reports. For PerkinElmer, Inc. (NYSE:PKI), the analyst expects potential upside from a China diagnostics recovery and a “compelling valuation.”

According to Insider Monkey’s fourth quarter database, 34 hedge funds were bullish on PerkinElmer, Inc. (NYSE:PKI), compared to 30 funds in the last quarter. Ken Griffin’s Citadel Investment Group is a prominent stakeholder of the company, with 1.28 million shares worth $179.5 million.

Renaissance Large Cap Growth Strategy made the following comment about PerkinElmer, Inc. (NYSE:PKI) in its Q4 2022 investor letter:

“Conversely, we sold our position in PerkinElmer, Inc. (NYSE:PKI) following a deterioration in fundamental factors. After a careful review, we believe the prudent decision is to step aside until the company completes the divestiture of its Applied, Food, and Enterprise Services business to private equity. While it allows PerkinElmer to become a pure-play Life Sciences & Diagnostics business, the divestiture will also produce a company that may operate with under-utilized assets until the new management team can deploy capital to rebuild its revenue base following the loss of approximately 30% of revenues.”

6. Roper Technologies, Inc. (NYSE:ROP)

Number of Hedge Fund Holders: 41

Roper Technologies, Inc. (NYSE:ROP) specializes in designing and developing software, as well as technology-enabled products and solutions. Furthermore, Roper Technologies, Inc. (NYSE:ROP) also provides scientific products and devices such as ultrasound accessories, dispensers, metering pumps, automated surgical scrub and linen dispensing equipment, water meters, optical and electromagnetic measurement systems, as well as medical devices. On April 27, the company reported a Q1 non-GAAP EPS of $3.90 and a revenue of $1.47 billion, outperforming Wall Street consensus by $0.04 and $20 million, respectively.

On May 2, TD Cowen analyst Joseph Giordano increased the price target for Roper Technologies, Inc. (NYSE:ROP) to $525 from $500 while maintaining an Outperform rating on the company’s shares. According to the analyst, Roper Technologies, Inc. (NYSE:ROP) delivered one of the strongest reports among similar companies during this season, and their diversified portfolio, focused on software in niche markets, is highly appealing as the market appears to be entering a period of cyclical weakness.

According to Insider Monkey’s fourth quarter database, 41 hedge funds were bullish on Roper Technologies, Inc. (NYSE:ROP), compared to 44 funds in the earlier quarter. Henry Ellenbogen’s Durable Capital Partners is the biggest stakeholder of the company, with 1.68 million shares worth $727.70 million.

In addition to Thermo Fisher Scientific Inc. (NYSE:TMO), Agilent Technologies, Inc. (NYSE:A), and Danaher Corporation (NYSE:DHR), Roper Technologies, Inc. (NYSE:ROP) is one of the top plays in the scientific instruments market.

Wasatch U.S. Select Strategy made the following comment about Roper Technologies, Inc. (NYSE:ROP) in its Q4 2022 investor letter:

“Roper Technologies, Inc. (NYSE:ROP) was another large contributor. The stock was up after the company released strong third-quarter financial results, including revenue and earnings growth that exceeded consensus expectations. Roper develops software and other engineered products for a variety of niche markets and industries. The company owns 26 independent businesses, most of which enjoy strong barriers to entry and leadership positions in their respective markets. The management team has done an exceptional job, in our view, of improving the operating performance and free cash flow generation of the businesses in its portfolio, then deploying that cash into acquiring new businesses that fit a similar profile. Roper’s ability to put up strong results in what’s been a challenging operating environment for many businesses speaks to the durability of the business.”

Click to continue reading and see 5 Best Scientific Instruments Stocks To Buy.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Published on October 6, 2025 at by Inan Dogan, PhD

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

175 Teslas
107 Amazons
140 Metas
84 Googles
65 Microsofts
And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

Insider Monkey Ads

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Published on October 5, 2025 at by Inan Dogan, PhD

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

AI is eating the world—and the machines behind it are ravenous.

Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink.

Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and building the digital future. But there’s one urgent question few are asking:

Where will all of that energy come from?

AI is the most electricity-hungry technology ever invented. Each data center powering large language models like ChatGPT consumes as much energy as a small city. And it’s about to get worse.

Even Sam Altman, the founder of OpenAI, issued a stark warning:

“The future of AI depends on an energy breakthrough.”

Elon Musk was even more blunt:

“AI will run out of electricity by next year.”

As the world chases faster, smarter machines, a hidden crisis is emerging behind the scenes. Power grids are strained. Electricity prices are rising. Utilities are scrambling to expand capacity.

And that’s where the real opportunity lies…

One little-known company—almost entirely overlooked by most AI investors—could be the ultimate backdoor play. It’s not a chipmaker. It’s not a cloud platform. But it might be the most important AI stock in the US owns critical energy infrastructure assets positioned to feed the coming AI energy spike.

As demand from AI data centers explodes, this company is gearing up to profit from the most valuable commodity in the digital age: electricity.

The “Toll Booth” Operator of the AI Energy Boom

It owns critical nuclear energy infrastructure assets, positioning it at the heart of America’s next-generation power strategy.
It’s one of the only global companies capable of executing large-scale, complex EPC (engineering, procurement, and construction) projects across oil, gas, renewable fuels, and industrial infrastructure.
It plays a pivotal role in U.S. LNG exportation—a sector about to explode under President Trump’s renewed “America First” energy doctrine.

Trump has made it clear: Europe and U.S. allies must buy American LNG.

And our company sits in the toll booth—collecting fees on every drop exported.

But that’s not all…

As Trump’s proposed tariffs push American manufacturers to bring their operations back home, this company will be first in line to rebuild, retrofit, and reengineer those facilities.

AI. Energy. Tariffs. Onshoring. This One Company Ties It All Together.

While the world is distracted by flashy AI tickers, a few smart investors are quietly scooping up shares of the one company powering it all from behind the scenes.

AI needs energy. Energy needs infrastructure.

And infrastructure needs a builder with experience, scale, and execution.

This company has its finger in every pie—and Wall Street is just starting to notice.

Wall Street is noticing this company also because it is quietly riding all of these tailwinds—without the sky-high valuation.

While most energy and utility firms are buried under mountains of debt and coughing up hefty interest payments just to appease bondholders…

This company is completely debt-free.

In fact, it’s sitting on a war chest of cash—equal to nearly one-third of its entire market cap.

It also owns a huge equity stake in another red-hot AI play, giving investors indirect exposure to multiple AI growth engines without paying a premium.

And here’s what the smart money has started whispering…

The Hedge Fund Secret That’s Starting to Leak Out

This stock is so off-the-radar, so absurdly undervalued, that some of the most secretive hedge fund managers in the world have begun pitching it at closed-door investment summits.

They’re sharing it quietly, away from the cameras, to rooms full of ultra-wealthy clients.

Why? Because excluding cash and investments, this company is trading at less than 7 times earnings.

And that’s for a business tied to:

The AI infrastructure supercycle
The onshoring boom driven by Trump-era tariffs
A surge in U.S. LNG exports
And a unique footprint in nuclear energy—the future of clean, reliable power

You simply won’t find another AI and energy stock this cheap… with this much upside.

This isn’t a hype stock. It’s not riding on hope.

It’s delivering real cash flows, owns critical infrastructure, and holds stakes in other major growth stories.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 100+% Return within 12 to 24 months.

We’re now offering month-to-month subscriptions with no commitments.

For a ridiculously low price of just $9.99 per month, you can unlock our in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

Access to our Detailed Report on our AI, Tariffs, and Nuclear Energy Stock with 100+% potential upside within 12 to 24 months
BONUS REPORT on our #1 AI-Robotics Stock with 10000% upside potential: Our in-depth report dives deep into our #1 AI/robotics stock’s groundbreaking technology and massive growth potential.
One New Issue of Our Premium Readership Newsletter: You will also receive one new issue per month and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.
One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149
Bonus Content: Premium access to members-only fund manager video interviews
Ad-Free Browsing: Enjoy a month of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.
Lifetime Price Guarantee: Your renewal rate will always remain the same as long as your subscription is active.
30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

Insider Monkey Ads

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Log In

Sign Up

10 Best Scientific Instruments Stocks To Buy

Published on May 8, 2023 at 3:15 pm by Hamna Asim in Hedge Funds, News

Best Scientific Instruments Stocks To Buy

10. Mirion Technologies, Inc. (NYSE:MIR)

9. Fortive Corporation (NYSE:FTV)

8. Teledyne Technologies Incorporated (NYSE:TDY)

7. PerkinElmer, Inc. (NYSE:PKI)

6. Roper Technologies, Inc. (NYSE:ROP)

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Published on October 6, 2025 at by Inan Dogan, PhD

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Published on October 5, 2025 at by Inan Dogan, PhD

Here’s why this is a deal you can’t afford to pass up:

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Premium

Log In

Sign Up

10 Best Scientific Instruments Stocks To Buy

Published on May 8, 2023 at 3:15 pm by Hamna Asim in Hedge Funds, News

Share

Best Scientific Instruments Stocks To Buy

10. Mirion Technologies, Inc. (NYSE:MIR)

9. Fortive Corporation (NYSE:FTV)

8. Teledyne Technologies Incorporated (NYSE:TDY)

7. PerkinElmer, Inc. (NYSE:PKI)

6. Roper Technologies, Inc. (NYSE:ROP)

Share

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Published on October 6, 2025 at by Inan Dogan, PhD

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Published on October 5, 2025 at by Inan Dogan, PhD

Here’s why this is a deal you can’t afford to pass up: